Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €77.00 ($89.53) price objective by investment analysts at HSBC in a research report issued on Thursday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. HSBC’s price target points to a potential upside of 25.41% from the stock’s current price.

Several other research firms have also weighed in on FME. Jefferies Financial Group set a €69.00 ($80.23) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a report on Wednesday, September 18th. Nord/LB set a €82.00 ($95.35) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Thursday, August 1st. Credit Suisse Group set a €71.00 ($82.56) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a report on Thursday, August 1st. Morgan Stanley set a €58.00 ($67.44) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a report on Thursday, September 12th. Finally, JPMorgan Chase & Co. set a €78.60 ($91.40) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Thursday. Seven research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of €79.21 ($92.10).

ETR:FME traded up €0.12 ($0.14) on Thursday, hitting €61.40 ($71.40). The stock had a trading volume of 782,845 shares, compared to its average volume of 704,197. The company has a quick ratio of 0.63, a current ratio of 0.99 and a debt-to-equity ratio of 105.17. The stock has a market cap of $18.59 billion and a price-to-earnings ratio of 15.23. The company has a fifty day moving average price of €61.14 and a two-hundred day moving average price of €66.72. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €55.44 ($64.47) and a 1-year high of €89.04 ($103.53).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Article: How is the discount rate different from the Federal Funds rate?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.